New Leaf Venture Partners’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

New Leaf Venture Partners’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-311,660	Closed	-$4.02M	–	21
2018 Q2	$4.02M	Sell	311,660 -540,837	-63%	-$7.31M	0.97%	12
2018 Q1	$10.6M	Hold	852,497	–	–	5.73%	5
2017 Q4	$11.9M	Hold	852,497	–	–	5.57%	6
2017 Q3	$14.3M	Sell	852,497 -100,000	-10%	-$1.63M	6.65%	4
2017 Q2	$16M	Sell	952,497 -200,000	-17%	-$2.99M	11.25%	4
2017 Q1	$17.9M	Sell	1,152,497 -225,000	-16%	-$3.21M	9.15%	5
2016 Q4	$20.6M	Hold	1,377,497	–	–	14.75%	3
2016 Q3	$17.3M	Hold	1,377,497	–	–	12.46%	4
2016 Q2	$12.4M	Hold	1,377,497	–	–	10.67%	4
2016 Q1	$13.7M	Hold	1,377,497	–	–	12.35%	4
2015 Q4	$15.8M	Hold	1,377,497	–	–	10.6%	5
2015 Q3	$18.6M	Hold	1,377,497	–	–	16.13%	3
2015 Q2	$19.1M	Hold	1,377,497	–	–	12.64%	3
2015 Q1	$19.4M	Hold	1,377,497	–	–	13.17%	3
2014 Q4	$18.8M	Buy	+1,377,497	New	+$18.8M	9.13%	4

Other funds holding OXFD

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

New Leaf Venture Partners's OXFD Position: Q3 2018 in Review

New Leaf Venture Partners sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q3 2018, closing a stake of 311,660 shares — an estimated $4.02M sold.

New Leaf Venture Partners first reported a position in OXFD in Q4 2014 and held it in 15 quarters. The position peaked at $20.6M in Q4 2016. 83 funds tracked by Wall St. Rank hold OXFD as of Q3 2018.

New Leaf Venture Partners reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q3 2018 after selling out during the quarter.
New Leaf Venture Partners sold 311,660 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2018, an estimated $4.02M.
New Leaf Venture Partners first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2014 and held it in 15 quarters.
New Leaf Venture Partners's Oxford Immunotec Global PLC Ordinary Shares position peaked at $20.6M in Q4 2016.
83 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2018.

Based on New Leaf Venture Partners's 13F filing for Q3 2018, filed 13 Nov 2018.